Cost-effectiveness of telehealth for patients with raised cardiovascular disease risk: evidence from the Healthlines randomised controlled trial.
about
Cost-effectiveness modelling of telehealth for patients with raised cardiovascular disease risk: evidence from a cohort simulation conducted alongside the Healthlines randomised controlled trial.Remote Patient Management for Home Dialysis Patients.Economic evaluations of eHealth technologies: A systematic review.
P2860
Cost-effectiveness of telehealth for patients with raised cardiovascular disease risk: evidence from the Healthlines randomised controlled trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cost-effectiveness of teleheal ...... s randomised controlled trial.
@en
Cost-effectiveness of teleheal ...... s randomised controlled trial.
@nl
type
label
Cost-effectiveness of teleheal ...... s randomised controlled trial.
@en
Cost-effectiveness of teleheal ...... s randomised controlled trial.
@nl
prefLabel
Cost-effectiveness of teleheal ...... s randomised controlled trial.
@en
Cost-effectiveness of teleheal ...... s randomised controlled trial.
@nl
P2093
P2860
P50
P1433
P1476
Cost-effectiveness of teleheal ...... s randomised controlled trial.
@en
P2093
Alexis Foster
Clare Thomas
Louisa Edwards
Shirley Large
P2860
P304
P356
10.1136/BMJOPEN-2016-012352
P577
2016-08-26T00:00:00Z